9820sek
0,4 %
Date:2024-04-19Time:17:29:31Latest report:Q4-2023List:Large CapTicker:ALIF B
Market Cap:12 025 msekEnterprise Value:17 217 msekNet Sales:9 685 msekEarnings:190,0 msekEmployees:0ISIN:SE0014401378

Ratios

10-year key figure history for AddLife turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for AddLife with index and moving average MA50 and MA200.

Stockprice:98,20
MA50:104,48
MA200:91,01
Price/MA200:7,9 %
RSI (14):34,1
Price/MA50:-6,0 %

Description

AddLife AB is engaged in the business of providing products, services, and advisory services. The company operates in Labtech and Medtech segments. The Labtech segment, which accounts for the majority of the company revenue, provides analytical instruments, equipment, microscopes, consumables, and reagents, as well as software support and technical service. The Medtech segment includes products related to surgery, thoracic medicine, neurology, wound care, anesthesia, intensive care, ear, nose and throat, ostomies, and home healthcare. AddLife mainly caters to hospitals & laboratories within healthcare, research, colleges, and universities, as well as the food and pharmaceutical industries. Its geographical segments are Sweden, Denmark, Finland, Norway, and Other countries.

Biotechnology